Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.
Tward JD, Huang HC, Esteva A, Mohamad O, van der Wal D, Simko JP, DeVries S, Zhang J, Joun S, Showalter TN, Schaeffer EM, Morgan TM, Monson JM, Wallace JA, Bahary JP, Sandler HM, Spratt DE, Rodgers JP, Feng FY, Tran PT. Tward JD, et al. Among authors: morgan tm. JCO Precis Oncol. 2024 Oct;8:e2400145. doi: 10.1200/PO.24.00145. Epub 2024 Oct 24. JCO Precis Oncol. 2024. PMID: 39447096 Free PMC article. Clinical Trial.
Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing.
Abusamra SM, Solorzano MA, Quarles J, Luke M, Patel M, Vince R Jr, Jiang R, Volin J, Jacobs MF, Kaffenberger SD, Salami SS, Palmbos P, Caram MEV, Hollenbeck BK, Palapattu GS, Merajver SD, Stoffel EM, Hafron J, Morgan TM, Reichert ZR. Abusamra SM, et al. Among authors: morgan tm. Urol Pract. 2025 Jan;12(1):63-72. doi: 10.1097/UPJ.0000000000000727. Epub 2024 Oct 9. Urol Pract. 2025. PMID: 39383006
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial.
Morgan TM, Daignault-Newton S, Spratt DE, Dunn RL, Singhal U, Okoth LA, Feng FY, Johnson AM, Lane BR, Linsell S, Ghani KR, Montie JE, Mehra R, Hollenbeck BK, Maatman T, Wojno K, Burks FN, Bekong D, Curry J, Rodriguez P, Kleer E, Sarle R, Miller DC, Cher ML. Morgan TM, et al. Eur Urol. 2024 Oct 7:S0302-2838(24)02604-6. doi: 10.1016/j.eururo.2024.09.011. Online ahead of print. Eur Urol. 2024. PMID: 39379238
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.
Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG, Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C, Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana SC, Taplin ME, Yamoah K, Fortune T, Bennett K, Blanding-Godbolt J, Gross L, Giri VN. Leader AE, et al. Among authors: morgan tm. BMC Public Health. 2024 Sep 18;24(1):2533. doi: 10.1186/s12889-024-20008-8. BMC Public Health. 2024. PMID: 39289635 Free PMC article.
Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testing.
Triner D, Graf RP, Madison RW, Gjoerup O, Tukachinsky H, Ross JS, Quintanilha JCF, Li G, Cheng HH, Pritchard CC, Zurita AJ, Qin Q, Zhang T, Agarwal N, Reichert ZR, Mateo J, Cieslik M, Morgan TM. Triner D, et al. Among authors: morgan tm. ESMO Open. 2024 Sep;9(9):103684. doi: 10.1016/j.esmoop.2024.103684. Epub 2024 Sep 9. ESMO Open. 2024. PMID: 39255537 Free PMC article.
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing.
Lenz L, Clegg W, Iliev D, Kasten CR, Korman H, Morgan TM, Hafron J, DeHaan A, Olsson C, Tutrone RF Jr, Richardson T, Cline K, Yonover PM, Jasper J, Cohen T, Finch R, Slavin TP Jr, Gutin A. Lenz L, et al. Among authors: morgan tm. Prostate Cancer Prostatic Dis. 2024 Sep 5. doi: 10.1038/s41391-024-00888-y. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39237680
Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response.
Merrill NM, Kaffenberger SD, Bao L, Vandecan N, Goo L, Apfel A, Cheng X, Qin Z, Liu CJ, Bankhead A, Wang Y, Kathawate V, Tudrick L, Serhan HA, Farah Z, Ellimoottil C, Hafez KS, Herrel LA, Montgomery JS, Morgan TM, Salami SS, Weizer AZ, Ulintz PJ, Day ML, Soellner MB, Palmbos PL, Merajver SD, Udager AM. Merrill NM, et al. Among authors: morgan tm. Eur Urol. 2024 Nov;86(5):434-444. doi: 10.1016/j.eururo.2024.05.026. Epub 2024 Aug 17. Eur Urol. 2024. PMID: 39155193
490 results